An interventional study of Novel locomotion treatment: curved-walking training and Standard locomotion treatment: straight-walking training in Stroke, Acute, Parkinson Disease and Femur Fracture, sponsored by Istituti Clinici Scientifici Maugeri SpA. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.
Sponsored by Istituti Clinici Scientifici Maugeri SpA · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Stroke by Istituti Clinici Scientifici Maugeri SpA — 6 open to participants now, 6 under way, none of them phase 3. Stroke · Istituti Clinici Scientifici Maugeri SpA.
Among the 10 studies in Stroke by Istituti Clinici Scientifici Maugeri SpA, this one is one of 3 that started in 2018, is one of 8 with no phase, and was the 2nd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →6 of the 10 studies in Stroke by Istituti Clinici Scientifici Maugeri SpA are open now, in 1 country. Recruiting first, the newest first:
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 18+
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 40–85 · Healthy volunteers
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 18+
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 18+
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages up to 80
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 3 started in 2018.
This study's planned enrollment of 210 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 105 across the 8 interventional studies, 218 across the 2 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Istituti Clinici Scientifici Maugeri SpA is the lead sponsor of 128 studies on the registry; 52 are open to participants now.
3 of the studies in Stroke by Istituti Clinici Scientifici Maugeri SpA that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07254390Istituti Clinici Scientifici Maugeri SpAEffects of Trans-Auricular Vagal Stimulation on Neuromotor Recovery in Subacute Stroke During Technological and Traditional Training | 2026-12-20 |
| NCT05706831Istituti Clinici Scientifici Maugeri SpAMusic Intervention and Transcranial Electrical Stimulation for Neurological Diseases | 2026-12-31 |
| NCT04876339Istituti Clinici Scientifici Maugeri SpASonification Techniques for Gait Training | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 10 studies in Stroke by Istituti Clinici Scientifici Maugeri SpA, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The recovery of walking ability is crucial to promote independence in daily living and is one of the major goal of neuromotor rehabilitation.
Currently, standard rehabilitative programs are usually based on straight-walking training (SWT) and the assessment of their effects is performed through functional scales based on straight-walking trajectories, e.g. Timed Up and Go (TUG), 10 meters walking test (10mWT).
Curved-walking training (CWT) may be interesting to provide an ecological and challenging context during rehabilitation. Indeed, CWT is based on demanding neural processes that drive an asymmetrical contribution at lower limb level, challenging balance ability and complex adaptation such as body weight shifting in response to centrifugal force and production of different step lengths.
Up to now, literature has investigated CWT in healthy adults in terms of muscular activation, kinematics and kinetics of the movement. Results showed that CWT needs a different biomechanical strategy with respect to SWT. Nevertheless CWT has not been investigated in pathological adults.
The present study aims at assessing the effectiveness of a rehabilitative physical therapy based on CWT with respect to traditional SWT for the recovery of locomotor abilities in neurological and orthopaedic patients.
The hypothesis is that a training based on curved-walking is ecologically meaningful and may be superior with respect to standard training in improving balance, walking abilities, and independence in activity of daily live of patients.
A secondary aim of the project is to propose an innovative functional scale based on the timed up and go on curved trajectory (CTUG), and to determine its reliability and responsiveness, establishing the minimum Detectable Change (MDC) and the Minimal Clinically Important Difference (MCID).
A single-blind randomized controlled study is being carried out on three different populations:
A healthy group is also being recruited to provide reference values of CTUG. For each of the three populations, subjects are randomized into two groups. The experimental one performs a novel rehabilitative program composed by a 30-minute training on curved trajectory ("S" trajectory composed by two semicircle with a radius of 1.2 m) in addition to usual care. The control group performs an equal dose of traditional treatment on straight trajectories.
Both groups undergo 20 90-minutes sessions of training (three times a week for seven weeks).
Participants are evaluated at baseline (T0), after training (T1), and at a three-months follow-up visit (T2).
The primary outcome measure is the 10mWT (minimal clinically important difference of 0.16 m/s identified by Tilson and colleagues). On the basis of this measure, a sample size of 70 subjects for each population was computed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
It consists of 20 sessions of training (three times a week for seven weeks) composed by standard physical therapy and a novel approach to locomotion rehabilitation based on curved-walking training. Each session lasts about 90 minutes.
Other: Novel locomotion treatment: curved-walking training · Other: Standard physical therapy
It consists of 20 sessions of training (three times a week for seven weeks) of standard physical therapy and conventional straight-walking training. Each session lasts about 90 minutes.
Other: Standard locomotion treatment: straight-walking training · Other: Standard physical therapy
Each training session is comprehensive of a 30-minute walking training on curved trajectory ("S" trajectory composed by two semicircle with a radius of 1.2 m)
It consists of 30 minutes of locomotion training on straight trajectories, as typically proposed during traditional gait rehabilitation
It consists of 60 minutes of stretching, muscular conditioning and coordination,postural exercises for trunk control, standing, functional exercies and upper limb rehabilitation, customized on patient's need.
Change in 10 meter walk test (10MWT)
Time (seconds) needed by patients to walk for 10 meters
Time frame: Baseline, 7 weeks, 20 weeks
curved-walking test
Time (seconds) needed to complete the "S" curved trajectory (7.53 m)
Time frame: Baseline, 7 weeks, 20 weeks
Timed Up and Go (TUG)
Time (seconds) needed to the patient to stand up upon therapist's command, walk 3 meters, turn around, walk back to the chair and sit down.
Time frame: Baseline, 7 weeks, 20 weeks
Curved Timed Up and Go
Time (seconds) needed to the patient to stand up upon therapist's command, walk 3 meters following the curved trajectory, turn around, walk back on the curved trajectory to the chair and sit down.
Time frame: Baseline (test), day 2 (retest), 7 weeks, 20 weeks
Balance test
Balance performance assessed by Balance test. Postural stability is evaluated using the commercial balance board Balance Master basicTM, NeuroCom® International, Inc. Assessments evaluate the postural sways during upright stance both with eyes open and closed; the limits of stability in different directions (forward, backward, right, and left); and the capability to shift the weight both left/right and forward/backward.
Time frame: Baseline, 7 weeks, 20 weeks
Pain Numerical Rating Scale
Pain perceived on 11 levels (0-10)
Time frame: Baseline, 7 weeks, 20 weeks
Short Form Healthy Survey SF-36
Healthy status investigated in 36 questions
Time frame: Baseline, 7 weeks, 20 weeks
Falls Efficacy Scale (FES)
Risk of falls evaluated with 10 elements, each scored from 0 to 10. A total score higher than 70 suggests fear of falls.
Time frame: Baseline, 7 weeks, 20 weeks
Global Perceived Effect (GPE) for patients
Perceived effectiveness of training for patients. A score from 1 (significantly improved) to 7 (significantly worsened) is assigned.
Time frame: 7 weeks
Global Perceived Effect (GPE) for physiotherapists
Perceived effectiveness of training for physiotherapists. A score from 1 (significantly improved) to 7 (significantly worsened) is assigned.
Time frame: 7 weeks
Motricity Index (MI)
Functional ability of limb - post-stroke population only. The quality of different limb movement are scored from 0 to 33 points, with a total score of 100 for each limb
Time frame: Baseline, 7 weeks, 20 weeks
39-Item Parkinson's Disease Questionnaire (PDQ-39)
Quality of life questionnaire - Parkinson's Disease only. The questionnaire is based on 39 questions and the total score ranges from 0% (no difficulty) to 100% (maximum level of difficulty)
Time frame: Baseline, 7 weeks, 20 weeks
Tampa Scale for Kinesiophobia (TSK)
Fear of movement - Parkinson's Disease only. Score ranges from 13 (no fear) to 52 (maximum fear).
Time frame: Baseline, 7 weeks, 20 weeks
Unified parkinson's Disease Rating Scale (UPDRS)
Parkinson's Disease prognosis information - Parkinson's Disease only. Score ranges from 0 (normal) to 199 (severe impairment).
Time frame: Baseline, 7 weeks, 20 weeks
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Physical functionality, pain and stiffness - post-femoral fracture only. Its score ranges from 0 (high healthy status) to 100 (low healthy status)
Time frame: Baseline, 7 weeks, 20 weeks
Started Jan 2018 (actual). Primary completion is estimated for Jan 2028, 120 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 120 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Jan 2023 → Jan 2028 and completion Jan 2023 → Jun 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istituti Clinici Scientifici Maugeri SpA →